Karen Jamison
Internal Medicine · San Diego, CANPI 1285830505
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,510 and has fallen 95.5% since, to $68 in 2025.
Across 218 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$952
- Amgen$423
- Pfizer$309
- AstraZeneca$254
- GSK$242
- Johnson & Johnson$223
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,95299%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $952 |
| Amgen | 20 | $423 |
| Pfizer | 17 | $309 |
| AstraZeneca(2 entities) | 14 | $254 |
| GSK | 11 | $242 |
| Johnson & Johnson | 13 | $223 |
| Merck | 8 | $152 |
| Astellas Pharma US Inc | 7 | $133 |
| Novartis | 7 | $109 |
| Lilly USA, LLC | 6 | $103 |
| Boehringer Ingelheim | 5 | $89 |
| Novo Nordisk | 6 | $88 |
| Grifols USA, LLC | 5 | $88 |
| Sanofi Pasteur Inc. | 4 | $74 |
| Eisai Inc. | 4 | $74 |
| Theratechnologies Inc. | 3 | $69 |
| Radius Health, Inc. | 3 | $59 |
| Vertos Medical, Inc. | 1 | $48 |
| Arbor Pharmaceuticals, Inc. | 2 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Topcon Healthcare Solutions, Inc. | 1 | $32 |
| Therapeuticsmd, Inc. | 2 | $31 |
| Bausch Health US, LLC | 2 | $27 |
| Seqirus USA Inc | 2 | $26 |
| Boston Scientific | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Medtronic | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Shionogi Inc | 1 | $17 |
| Exeltis, USA Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Vertiflex, Inc. | 1 | $15 |
| Gilead | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Metuchen Pharmaceuticals | 1 | $11 |
How this compares
$3,976 in reported general payments places this provider in the 85th percentile of 13,581 internal medicine providers in California.
Other internal medicine in San Diego
- Hatim HusainSan Diego$2M
- Steven EdelmanSan Diego$863K
- Christian RamersSan Diego$675K
- Adam ZweigSan Diego$421K
- James BreitmeyerSan Diego$227K
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Teck LingPalo Alto$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.